Skip to main content
logo
Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.51
-0.41 (-5.92%)
May 18, 2026, 4:00 PM EDT - Market closed

Solid Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
641445162125105193
Market Cap Growth
126.63%175.14%29.32%18.97%-45.51%-69.99%
Enterprise Value
280.89275.3734.1125.47-82.52-14.12
Last Close Price
6.515.644.006.145.3826.25
PE Ratio
--2.83-1.31-1.27-0.53-2.59
PS Ratio
----13.0014.18
PB Ratio
1.712.471.180.990.500.93
P/TBV Ratio
1.712.741.190.970.220.90
P/FCF Ratio
--2.83-1.61-1.31-1.04-2.44
P/OCF Ratio
--2.85-1.62-1.33-1.07-2.48
EV/Sales Ratio
-----10.20-1.04
EV/EBITDA Ratio
--1.55-0.27-0.250.790.20
EV/EBIT Ratio
--1.54-0.26-0.240.780.20
EV/FCF Ratio
--1.75-0.34-0.270.820.18
Debt / Equity Ratio
0.050.110.150.190.120.00
Debt / EBITDA Ratio
-0.11-0.12-0.19-0.26-0.27-0.03
Debt / FCF Ratio
-0.12-0.13-0.24-0.27-0.28-0.03
Net Debt / Equity Ratio
-0.96-0.93-0.91-0.77-0.87-0.99
Net Debt / EBITDA Ratio
1.850.950.980.961.782.97
Net Debt / FCF Ratio
2.091.071.241.021.832.60
Asset Turnover
-0000.030.07
Quick Ratio
12.595.654.928.529.508.81
Current Ratio
13.106.145.208.949.769.43
Return on Equity (ROE)
-69.22%-109.90%-94.57%-56.79%-40.96%-42.43%
Return on Assets (ROA)
-59.95%-85.09%-73.38%-49.04%-43.22%-35.81%
Return on Invested Capital (ROIC)
-1030.51%-969.94%-579.67%-374.29%-572.15%-955.68%
Return on Capital Employed (ROCE)
-66.41%-100.26%-84.01%-53.72%-47.68%-40.65%
Earnings Yield
-29.92%-35.28%-76.50%-78.66%-187.73%-38.63%
FCF Yield
-26.97%-35.35%-62.19%-76.45%-95.99%-40.94%
Buyback Yield / Dilution
-105.53%-114.38%-105.27%-133.60%-19.59%-105.58%
Total Shareholder Return
-105.53%-114.38%-105.27%-133.60%-19.59%-105.58%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q